Peptides and peptidomimetics binding to cd23

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/532 (2006.01) A61K 38/08 (2006.01) C07K 7/06 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2560726

The present invention describes compounds comprising new and useful peptides and peptidomimetics that can bind to CD23. They are capable of reducing inflammatory responses associated with auto-immune diseases, chronic inflammatory diseases, allergies and other inflammatory conditions such as those mediated by the mammalian immune system. Compounds of the present invention relate to a CD23-binding peptide wherein said peptide comprises an amino-acid sequence of X1-X2- X3-X4-X5-X6-X7-X8, wherein: X1 is Phe, or is absent; X2 is His or Ala; X3 is Glu, Ser, Ala, Asn, Lys, or Cys; X4 is Asn, Phe, Gln, Pro, Ser, or Ala; X5 is Trp; X6 is Pro, Arg, Glu, Gly, Cys, or Lys; X7 is Ser, Pro, Leu, Thr Ala, Gly, Asn, or absent; and X8 is Phe, Gly, or is absent.

La présente invention concerne des composés comprenant de nouveaux peptides et peptidomimétiques utiles pouvant se lier à CD23. Ces composés permettent de réduire les réactions inflammatoires associées à des maladies auto-immunes, à des maladies inflammatoires chroniques, à des allergies et à d'autres affections inflammatoires telles que celle médiées par le système immunitaire des mammifères. Les composés de la présente invention comprennent un peptide se liant à CD23, ce peptide renfermant une séquence d'acides aminés de formule X1-X2- X3-X4-X5-X6-X7-X8, dans laquelle X1 est Phe ou est absent, X2 est His ou Ala, X3 est Glu, Ser, Ala, Asn, Lys ou Cys, X4 est Asn, Phe, Gln, Pro, Ser ou Ala, X5 est Trp, X6 est Pro, Arg, Glu, Gly, Cys ou Lys, X7 est Ser, Pro, Leu, Thr Ala, Gly ou Asn ou est absent, et X8 est Phe ou Gly ou est absent.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptides and peptidomimetics binding to cd23 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides and peptidomimetics binding to cd23, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and peptidomimetics binding to cd23 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1719279

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.